國立虎尾科技大學 |

Challenges and solutions against visceral leishmaniasis

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Challenges and solutions against visceral leishmaniasis/ edited by Angamuthu Selvapandiyan ... [et al.].
other author:	Selvapandiyan, Angamuthu.
Published:	Singapore :Springer Nature Singapore : : 2023.,
Description:	xxi, 449 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
Subject:	Kala-azar. -
Online resource:	https://doi.org/10.1007/978-981-99-6999-9
ISBN:	9789819969999

Challenges and solutions against visceral leishmaniasis
Challenges and solutions against visceral leishmaniasis[electronic resource] /edited by Angamuthu Selvapandiyan ... [et al.]. - Singapore :Springer Nature Singapore :2023. - xxi, 449 p. :ill. (some col.), digital ;24 cm.

Module 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development.

This book comprehensively reviews the epidemiology and surveillance strategies of Visceral Leishmaniasis, and the latest developments in disease diagnosis, drug discovery, and vaccine development. The initial chapters cover the epidemiology features and spatial distribution of Visceral Leishmaniasis. The book further discusses the manifestations of HIV-Visceral Leishmaniasis infection on the immunopathogenesis, diagnosis, and therapeutic response. It analyzes the role of different proteomic technologies in understanding the parasite development, survival, drug resistance mechanisms, host-pathogen interactions, and the development of new therapeutic approaches. The book concludes by discussing recent advancements in vaccine development for Visceral Leishmaniasis. It discusses the promising vaccine candidate, their developmental status, current challenges, and prospects for rational vaccine development against Leishmania. This book is an invaluable source of information for students, and researchers working to understand the Leishmania biology, and drug development.

ISBN: 9789819969999

Standard No.: 10.1007/978-981-99-6999-9doiSubjects--Topical Terms:

1436301
Kala-azar.

LC Class. No.: RC152

Dewey Class. No.: 616.9364

Challenges and solutions against visceral leishmaniasis
LDR:02276nam a2200325 a 4500 001 1120804
003 DE-He213
005 20240127073637.0
006 m d
007 cr nn 008maaau
008 240612s2023 si s 0 eng d
020 $a 9789819969999 $q (electronic bk.)
020 $a 9789819969982 $q (paper)
024 7 $a 10.1007/978-981-99-6999-9 $2 doi
035 $a 978-981-99-6999-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC152
072 7 $a PSGH $2 bicssc
072 7 $a MED103000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.9364 $2 23
090 $a RC152 $b .C437 2023
245 0 0 $a Challenges and solutions against visceral leishmaniasis $h [electronic resource] / $c edited by Angamuthu Selvapandiyan ... [et al.].
260 $a Singapore : $c 2023. $b Springer Nature Singapore : $b Imprint: Springer,
300 $a xxi, 449 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Module 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development.
520 $a This book comprehensively reviews the epidemiology and surveillance strategies of Visceral Leishmaniasis, and the latest developments in disease diagnosis, drug discovery, and vaccine development. The initial chapters cover the epidemiology features and spatial distribution of Visceral Leishmaniasis. The book further discusses the manifestations of HIV-Visceral Leishmaniasis infection on the immunopathogenesis, diagnosis, and therapeutic response. It analyzes the role of different proteomic technologies in understanding the parasite development, survival, drug resistance mechanisms, host-pathogen interactions, and the development of new therapeutic approaches. The book concludes by discussing recent advancements in vaccine development for Visceral Leishmaniasis. It discusses the promising vaccine candidate, their developmental status, current challenges, and prospects for rational vaccine development against Leishmania. This book is an invaluable source of information for students, and researchers working to understand the Leishmania biology, and drug development.
650 0 $a Kala-azar. $3 1436301
650 0 $a Kala-azar $x Diagnosis. $3 1436302
650 0 $a Kala-azar $x Treatment. $3 1436303
650 1 4 $a Parasitology. $3 669054
650 2 4 $a Structure-Based Drug Design. $3 1366842
650 2 4 $a Pharmaceutics. $3 1366841
650 2 4 $a Epidemiology. $3 635923
700 1 $a Selvapandiyan, Angamuthu. $3 1436300
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-6999-9
950 $a Medicine (SpringerNature-11650)